13 May 2025
Generics Unleashed: Jardiance Patent Expiry Rocks India’s Pharma Scene
March 11th, 2025, marked a seismic shift in India’s pharmaceutical landscape. With the patent expiry of Jardiance (empagliflozin)—a blockbuster anti-diabetic drug originally developed by Boehringer Ingelheim—the gates opened for generic manufacturers to enter the market. And enter they did, in full force. Almost overnight, major Indian pharmaceutical players such as Mankind Pharma and Lupin rolled […]
Read more
16192 Coastal Highway, Lewes, Delaware 19958, USA